Jeremy Grantham Edwards Lifesciences Corp Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $204,900 - $262,320	3,000 New	3,000 $223,000
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $526,093 - $780,138	-6,082 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $620,120 - $780,563	6,082 New	6,082 $716,000
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $2.83 Million - $3.54 Million	-33,763 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $12 Million - $13.9 Million	-152,900 Reduced 81.91%	33,763 $2.82 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $12.8 Million - $16.3 Million	179,064 Added 2356.42%	186,663 $17 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $510,576 - $664,456	7,599 New	7,599 $607,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.